Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Acquires Molecular Staging s Amplification Technology for $28.5M

NEW YORK, Sept. 27 (GenomeWeb News) - Qiagen today said that it has acquired technology assets from Molecular Staging, including the company's whole-genome amplification and rolling-circle amplification technologies, for $28.5 million.


Under the terms of the agreement, Qiagen purchased the technology assets of MSI, including more than 160 applied or issued patents, for $28.5 million in cash plus potential earn-outs of up to $6.75 million.


Qiagen said it expects to incur one-time charges relating to the acquisition of around $2 million in the third quarter of 2004, and that it expects the acquisition to add approximately $6 million in net sales and $1 million in net income in 2005.


The company said it plans to launch a series of kits integrating the WGA technology with its own nucleic acid products by early 2005.


Molecular Staging's WGA activities will be integrated into Qiagen's operations in Germantown, Md., and Hilden, Germany.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.